86 related articles for article (PubMed ID: 16274043)
21. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the immediate early response gene X-1 (IEX-1) expression in pancreatic cancer.
Sasada T; Azuma K; Hirai T; Hashida H; Kanai M; Yanagawa T; Takabayashi A
Ann Surg Oncol; 2008 Feb; 15(2):609-17. PubMed ID: 18026799
[TBL] [Abstract][Full Text] [Related]
23. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.
Dittert DD; Kielisch C; Alldinger I; Zietz C; Meyer W; Dobrowolski F; Saeger HD; Baretton GB
Hum Pathol; 2008 Jul; 39(7):1002-10. PubMed ID: 18495213
[TBL] [Abstract][Full Text] [Related]
25. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
26. CD74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy.
Nagata S; Jin YF; Yoshizato K; Tomoeda M; Song M; Iizuka N; Kitamura M; Takahashi H; Eguchi H; Ohigashi H; Ishikawa O; Tomita Y
Ann Surg Oncol; 2009 Sep; 16(9):2531-8. PubMed ID: 19499276
[TBL] [Abstract][Full Text] [Related]
27. [Clinical features and prognosis of intraductal papillary mucinous neoplasms of pancreas: analysis of 38 cases].
Lou WH; Wang DS; Ji Y; Xu XF; Kuang TT; Ni XL; Wu WC; Jin DY
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):947-50. PubMed ID: 16759531
[TBL] [Abstract][Full Text] [Related]
28. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times.
Kristiansen G; Jacob J; Buckendahl AC; Grützmann R; Alldinger I; Sipos B; Klöppel G; Bahra M; Langrehr JM; Neuhaus P; Dietel M; Pilarsky C
Clin Cancer Res; 2006 Nov; 12(21):6444-51. PubMed ID: 17085658
[TBL] [Abstract][Full Text] [Related]
30. BCL-2, TP53 and BAX protein expression in superficial urothelial bladder carcinoma.
Gonzalez-Campora R; Davalos-Casanova G; Beato-Moreno A; Garcia-Escudero A; Pareja Megia MJ; Montironi R; Lopez-Beltran A
Cancer Lett; 2007 Jun; 250(2):292-9. PubMed ID: 17126995
[TBL] [Abstract][Full Text] [Related]
31. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
[TBL] [Abstract][Full Text] [Related]
32. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of p53 expression in primary invasive ductal carcinoma of the pancreas between Chinese and Japanese.
Dong M; Nio Y; Sato Y; Tamura K; Song MM; Tian YL; Dong YT
Pancreas; 1998 Oct; 17(3):229-37. PubMed ID: 9788535
[TBL] [Abstract][Full Text] [Related]
34. BCL-2, BAX and P53 expression profiles in endometrial carcinoma as studied by real-time PCR and immunohistochemistry.
Porichi O; Nikolaidou ME; Apostolaki A; Tserkezoglou A; Arnogiannaki N; Kassanos D; Margaritis L; Panotopoulou E
Anticancer Res; 2009 Oct; 29(10):3977-82. PubMed ID: 19846939
[TBL] [Abstract][Full Text] [Related]
35. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
36. Bax expression in untreated breast cancer: an immunocytometric study of 255 cases.
Martínez-Arribas F; Martín-Garabato E; Zapardiel I; Sánchez J; Lucas AR; Tejerina A; Schneider J
Anticancer Res; 2008; 28(5A):2595-8. PubMed ID: 19035283
[TBL] [Abstract][Full Text] [Related]
37. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis.
Salakou S; Kardamakis D; Tsamandas AC; Zolota V; Apostolakis E; Tzelepi V; Papathanasopoulos P; Bonikos DS; Papapetropoulos T; Petsas T; Dougenis D
In Vivo; 2007; 21(1):123-32. PubMed ID: 17354625
[TBL] [Abstract][Full Text] [Related]
38. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
Jung JT; Kim DH; Kwak EK; Kim JG; Park TI; Sohn SK; Do YR; Kwon KY; Song HS; Park EH; Lee KB
Ann Hematol; 2006 Sep; 85(9):575-81. PubMed ID: 16673127
[TBL] [Abstract][Full Text] [Related]
39. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
Casneuf VF; Fonteyne P; Van Damme N; Demetter P; Pauwels P; de Hemptinne B; De Vos M; Van de Wiele C; Peeters M
Cancer Invest; 2008 Oct; 26(8):852-9. PubMed ID: 18853313
[TBL] [Abstract][Full Text] [Related]
40. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
